Senseonics (NYSE:SENS) Sets New 12-Month High – Here’s What Happened

Shares of Senseonics Holdings, Inc. (NYSE:SENS) reached a new 52-week high on Thursday . The stock traded as high as $0.85 and last traded at $0.84, with a volume of 16359777 shares trading hands. The stock had previously closed at $0.71.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on SENS. StockNews.com started coverage on shares of Senseonics in a research report on Thursday, December 26th. They issued a “sell” rating on the stock. HC Wainwright reissued a “buy” rating and issued a $2.00 target price on shares of Senseonics in a report on Friday, November 15th.

Senseonics Stock Performance

The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47. The stock has a 50 day moving average of $0.41 and a 200 day moving average of $0.40. The stock has a market capitalization of $511.98 million, a P/E ratio of -6.63 and a beta of 0.64.

Insider Transactions at Senseonics

In other Senseonics news, CFO Frederick T. Sullivan purchased 124,933 shares of Senseonics stock in a transaction on Thursday, December 12th. The stock was bought at an average price of $0.38 per share, for a total transaction of $47,474.54. Following the transaction, the chief financial officer now owns 2,478,844 shares of the company’s stock, valued at $941,960.72. The trade was a 5.31 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Timothy T. Goodnow purchased 315,000 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The stock was acquired at an average cost of $0.31 per share, with a total value of $97,650.00. Following the purchase, the chief executive officer now owns 11,310,355 shares of the company’s stock, valued at approximately $3,506,210.05. This represents a 2.86 % increase in their position. The disclosure for this purchase can be found here. Insiders own 3.60% of the company’s stock.

Institutional Trading of Senseonics

A number of institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC increased its stake in shares of Senseonics by 3.2% during the third quarter. Geode Capital Management LLC now owns 5,838,396 shares of the company’s stock valued at $2,042,000 after acquiring an additional 179,103 shares during the period. Symmetry Partners LLC bought a new position in Senseonics during the 3rd quarter valued at $164,000. Cubist Systematic Strategies LLC increased its position in shares of Senseonics by 25.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock valued at $166,000 after purchasing an additional 85,501 shares during the period. GSA Capital Partners LLP bought a new stake in shares of Senseonics in the 3rd quarter worth $117,000. Finally, FMR LLC lifted its holdings in shares of Senseonics by 48,267.2% in the third quarter. FMR LLC now owns 168,318 shares of the company’s stock valued at $59,000 after buying an additional 167,970 shares during the period. 12.36% of the stock is owned by institutional investors and hedge funds.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.